The DOI matches its Crossref record; 107 of the 109 references it cites were found in a registry or an index.
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Open accessAbstract
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a common quality control (QC)/quality assurance (QA) procedure to maintain the accuracy and precision of quantitation. Repeatability and reproducibility are two essential requirements for any quantitative measurement and/or imaging biomarker. Repeatability relates to the uncertainty in obtaining the same result in the same patient when he or she is examined more than once on the same system. However, imaging biomarkers should also have adequate reproducibility, i.e. the ability to yield the same result in the same patient when that patient is examined on different systems and at different imaging sites. Adequate repeatability and reproducibility are essential for the clinical management of patients and the use of FDG PET/CT within multicentre trials. A common standardised imaging procedure will help promote the appropriate use of FDG PET/CT imaging and increase the value of publications and, therefore, their contribution to evidence-based medicine. Moreover, consistency in numerical values between platforms and institutes that acquire the data will potentially enhance the role of semiquantitative and quantitative image interpretation. Precision and accuracy are additionally important as FDG PET/CT is used to evaluate tumour response as well as for diagnosis, prognosis and staging. Therefore both the previous and these new guidelines specifically aim to achieve standardised uptake value harmonisation in multicentre settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The European and American guidelines for PET/CT imaging recommended the measurement of blood glucose level prior to scanning and rescheduling the examination whenever the level exceeds 200 mg/dL.[5,6]”
From Intrapatient variability of 18F-FDG uptake in normal tissues (2022) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although all these errors are potentially severe, it should be noted that they can easily be avoided by following existing guidelines published by the EANM [24] or the EANM Research Ltd. (EARL) initiative [67].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interpretation of PET images in routine clinical practice primarily follows visual criteria, i.e., the assessment of generalized or focal pathologies in tracer accumulation, while quantitative parameters, including SUV, provide orientation or additional information at most [24].”
From Influences on PET Quantification and Interpretation (2022) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“European Association of Nuclear Medicine (EANM) [40] guidelines suggest if the plasma glucose level is higher than or equal to 200 mg/dl, the FDG PET/CT study should be rescheduled.”
From Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2019) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Current available PET-scan preparation protocols suggest rescheduling the scan or consideration of rapid-acting insulin injection prior to PET scan or scan rescheduling in patients with hyperglycemia ranging from 120 mg/dl to 200 mg/dl, and recommend inconsistent and diverse cut-offs for insulin injection or scan rescheduling [39,40].”
From Effect of blood glucose level on standardized uptake value (SUV) in 18F-FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2019) · cites this paper as [40]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777 · cited 8×
“2-cm diameter (or 1-mL volume) spherical VOI [61] positioned such that the average value across all positions within the lesion is maximized.”
InfluentialUniversity of California, San Francisco
(1974) · Medical History · doi:10.1017/s0025727300019682 · Cited by 2,222
Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
Self-citationBarrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Müeller, S. P., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.5229 · Cited by 1,665 · cited 1×
“Further, a fivepoint scale has been proposed for assessment of lymphoma therapy response [80].”
Self-citationJuweid, M. E., Stroobants, S., Hoekstra, O. S., Mottaghy, F. M., Dietlein, M., Guermazi, A., Wiseman, G. A., Kostakoglu, L., Scheidhauer, K., Buck, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2305 · Cited by 1,335 · cited 2×
“Some criteria have already been proposed [78, 79].”
Self-citationFDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0
Boellaard, R., O’Doherty, M. J., Weber, W. A., Mottaghy, F. M., Lonsdale, M. N., Stroobants, S. G., Oyen, W. J. G., Kotzerke, J., Hoekstra, O. S., Pruim, J., et al. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1297-4 · Cited by 1,326 · cited 6×
“• The effects of growth factors (G-CSF and GM-CSF) on FDG biodistribution (due to enhanced bone marrow uptake) generally last for more than 2 weeks after the final administration [20].”
InfluentialSelf-citationRecommendations on the Use of 18F-FDG PET in Oncology
Fletcher, J. W., Djulbegovic, B., Soares, H. P., Siegel, B. A., Lowe, V. J., Lyman, G. H., Coleman, R. E., Wahl, R., Paschold, J. C., Avril, N., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.047787 · Cited by 1,101
Self-citationStandards for PET Image Acquisition and Quantitative Data Analysis
Boellaard, R. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057182 · Cited by 902 · cited 4×
“This requires reconstruction settings to be chosen such as to achieve matching convergence and spatial resolution across various systems and sites, especially within a multicentre setting [48, 58, 59].”
InfluentialSelf-citationQuantification of Lean Bodyweight
Janmahasatian, S., Duffull, S. B., Ash, S., Ward, L. C., Byrne, N. M., & Green, B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00004 · Cited by 900 · cited 1×
“[62]: LBM = 9,270 × weight/(6,680 + 216 × BMI) LBM = 9,270 × weight/(8,780 + 244 × BMI) where LBM and LBM are the LBM for males and females, and BMI is body mass index (weight/height), and weight and height are in kilograms and centimetres, respectively.”
Report on the First International Workshop on interim-PET scan in lymphoma
Meignan, M., Gallamini, A., Meignan, M., Gallamini, A., & Haioun, C. (2009) · Leukemia & Lymphoma · doi:10.1080/10428190903040048 · Cited by 754 · cited 2×
“Some criteria have already been proposed [78, 79].”
Research works printed but not linked: 1
- Padhani AR. Imaging in the evaluation of cancer. In: Nicholson T, editor. Recommendations for cross-sectional imaging in cancer management. 2nd ed. London: The Royal College of Radiologists; 2014.
Cited by
Zwanenburg, A., Vallières, M., Abdalah, M. A., Aerts, H. J. W. L., Andrearczyk, V., Apte, A., Ashrafinia, S., Bakas, S., Beukinga, R. J., Boellaard, R., et al. (2020) · Radiology · doi:10.1148/radiol.2020191145 · Cited by 4,177
Self-citationApplications and limitations of radiomics
Yip, S. S. F., & Aerts, H. J. W. L. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/13/r150 · Cited by 1,210
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
“ADC, the family of K and related perfusion biomarkers derived from either CT or MRI and (18)F-fluorothymidine PET) continue to be measured and analysed in disparate ways by different laboratories using a wide range of software systems, despite attempts to standardise and harmonise these methods (2, 3, 11-14).”
Self-citationLactate: the ugly duckling of energy metabolism
Rabinowitz, J. D., & Enerbäck, S. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0243-4 · Cited by 1,049
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)
Zhou, J., Sun, H., Wang, Z., Cong, W., Wang, J., Zeng, M., Zhou, W., Bie, P., Liu, L., Wen, T., et al. (2020) · Liver Cancer · doi:10.1159/000509424 · Cited by 800
Metadata
- Authors
- Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., Stroobants, S., Delbeke, D., Donohoe, K. J., Holbrook, S., Graham, M. M., Testanera, G., Hoekstra, O. S., Zijlstra, J., Visser, E., Hoekstra, C. J., Pruim, J., Willemsen, A., Arends, B., Kotzerke, J., Bockisch, A., Beyer, T., Chiti, A., & Krause, B. J.
- Affiliations
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Radboud University Medical Center (NL)
- Hospices Civils de Lyon (FR)
- Städtisches Klinikum Karlsruhe (DE)
- University of Cologne (DE)
- Erasmus MC (NL)
- St Thomas' Hospital (GB)
- Memorial Sloan Kettering Cancer Center (US)
- Antwerp University Hospital (BE)
- Vanderbilt University Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Insilico Medicine (United States) (US)
- University of Iowa (US)
- Humanitas University (IT)
- Jeroen Bosch Ziekenhuis (NL)
- University Medical Center Groningen (NL)
- Catharina Ziekenhuis (NL)
- University Hospital Carl Gustav Carus (DE)
- Essen University Hospital (DE)
- Medical University of Vienna (AT)
- Universitätsmedizin Rostock (DE)
- Corresponding author
- Boellaard, Ronald
- ORCID
- Venue
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2014-12-02
- Volume
- 42
- Issue
- 2
- Pages
- 328-354
- ISSN
- 1619-7070 (ISSN-L)
- 1619-7089
- PMC
- PMC4315529
- OpenAlex
- W2088783247
- Cited by
- 3,303
- References
- 109
- Citations by year
- 2026: 306 · 2025: 341 · 2024: 388 · 2023: 333 · 2022: 405 · 2021: 408 · 2020: 296 · 2019: 258 · 2018: 230 · 2017: 159 · 2016: 115 · 2015: 54
- FWCI
- 85.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- European Journal of Nuclear Medicine and Molecular Imaging (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Radboud Repository (Radboud University) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Lung Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- FDG PET/CT, tumor imaging, standardized uptake value, quantitative imaging, quality control, quality assurance, repeatability, reproducibility, imaging biomarkers, tumor response assessment, tumor staging, cancer diagnosis, cancer prognosis, EANM guidelines
- MeSH terms
- Humans, Neoplasms, Tomography, X-Ray Computed, Radiopharmaceuticals, Fluorodeoxyglucose F18, Positron-Emission Tomography, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. https://app.cochat.ai/papers/10.1007/s00259-014-2961-x
- The paper
- Boellaard, R., Delgado-Bolton, R., Oyen, W. J. G., Giammarile, F., Tatsch, K., Eschner, W., Verzijlbergen, F. J., Barrington, S. F., Pike, L. C., Weber, W. A., Stroobants, S., Delbeke, D., Donohoe, K. J., Holbrook, S., Graham, M. M., Testanera, G., Hoekstra, O. S., Zijlstra, J., Visser, E., . . . Krause, B. J. (2015). FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-014-2961-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.